Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Glossary of Hostile Takeover Terms with Discussion
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5195499"]There are 1.4 bearish puts on Allergan for each call outstanding, close to the highest level since 2008, according to data compiled by Bloomberg. Last week, two-month contracts betting on a decline in the shares reached the most expensive level since 2011, compared with those betting on a gain.</p><p><br /></p><p>The battle is stretching into a fifth month. Allergan has rejected two takeover proposals, said it may do its own deal to fend off the suitor and filed a lawsuit alleging insider trading between Valeant and hedge-fund manager Ackman, whose Pershing Square Capital Management LP owns 9.4 percent of Allergan shares.</p><p><br /></p><p>“People were impressed when Ackman took a stake and kind of saw it as an ordained conclusion that he would get Allergan,” Scott Houlihan, a merger arbitrage research analyst at Purchase, New York-based Ota Limited Partnership, said via phone. “I imagine everyone in the arb community underestimated the will of these guys to get away.”[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5195499"]There are 1.4 bearish puts on Allergan for each call outstanding, close to the highest level since 2008, according to data compiled by Bloomberg. Last week, two-month contracts betting on a decline in the shares reached the most expensive level since 2011, compared with those betting on a gain. The battle is stretching into a fifth month. Allergan has rejected two takeover proposals, said it may do its own deal to fend off the suitor and filed a lawsuit alleging insider trading between Valeant and hedge-fund manager Ackman, whose Pershing Square Capital Management LP owns 9.4 percent of Allergan shares. “People were impressed when Ackman took a stake and kind of saw it as an ordained conclusion that he would get Allergan,” Scott Houlihan, a merger arbitrage research analyst at Purchase, New York-based Ota Limited Partnership, said via phone. “I imagine everyone in the arb community underestimated the will of these guys to get away.”[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Glossary of Hostile Takeover Terms with Discussion
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Glossary of Hostile Takeover Terms with Discussion
>